Study of Gecacitinib-corticosteroid as First-line Therapy for Grade II-IV Acute Graft Versus Host Disease

NCT07185633 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

aGVHD

Interventions

DRUG: Gecacitinib-Corticosteroid
DRUG: Methylprednisolone sodium succinate

Sponsor

Bin Gu